Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones

Oct 05, 2024

DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 1.77% to $5.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.22% to 18,137.85 and the Dow Jones Industrial Average rising 0.81% to 42,352.75.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed $9.20 short of its 52-week high ($14.75), which the company reached on April 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.13% to $160.29, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 0.85% to $28.58.

Trading volume (369,620) eclipsed its 50-day average volume of 297,909.

Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

October 04, 2024 17:28 ET (21:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2473913521"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2473913521\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2473913521?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-05 05:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2473913521","market":"us","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slid 1.77% to $5.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.22% to 18,137.85 and the Dow Jones Industrial Average  rising 0.81% to 42,352.75. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed $9.20 short of its 52-week high ($14.75), which the company reached on April 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.13% to $160.29, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) fell 50.00% to $0.00, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> rose 0.85% to $28.58. \n</p>\n<p>\n     Trading volume (369,620) eclipsed its 50-day average volume of 297,909. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 04, 2024 17:28 ET (21:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-10-05 05:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slid 1.77% to $5.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.22% to 18,137.85 and the Dow Jones Industrial Average  rising 0.81% to 42,352.75. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed $9.20 short of its 52-week high ($14.75), which the company reached on April 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.13% to $160.29, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) fell 50.00% to $0.00, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> rose 0.85% to $28.58. \n</p>\n<p>\n     Trading volume (369,620) eclipsed its 50-day average volume of 297,909. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 04, 2024 17:28 ET (21:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INO","symbol_name":"伊诺维奥制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2473913521","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2473913521","pubTimestamp":1728077280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slid 1.77% to $5.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.22% to 18,137.85 and the Dow Jones Industrial Average  rising 0.81% to 42,352.75.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed $9.20 short of its 52-week high , which the company reached on April 1st.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.13% to $160.29, Statera Biopharma Inc.  fell 50.00% to $0.00, and Pfizer Inc.  rose 0.85% to $28.58.Trading volume  eclipsed its 50-day average volume of 297,909.Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published indepen","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INO":"伊诺维奥制药"},"translate_title":"与竞争对手相比，Inovio Pharmaceuticals Inc.股票周五表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1},"content_text":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 1.77% to $5.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.22% to 18,137.85 and the Dow Jones Industrial Average  rising 0.81% to 42,352.75. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Inovio Pharmaceuticals Inc. closed $9.20 short of its 52-week high ($14.75), which the company reached on April 1st. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.13% to $160.29, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 0.85% to $28.58. \n\n\n     Trading volume (369,620) eclipsed its 50-day average volume of 297,909. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 04, 2024 17:28 ET (21:28 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}